ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Autolus Therapeutics (AUTL)

Technical Analysis Report for USA stock AUTL Autolus Therapeutics. Dated: 20 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics then click here. or read Experts views on Autolus Therapeutics or Forecast & share price targets of Autolus Therapeutics

Autolus Therapeutics Opened at 1.43 and Closed at: 1.38, which is -4.35% of previous session's close. It moved within a range of 1.36 and 1.48
The session was a Bearish session with an average volume of 1540247, which is 26.08% of previous session's volumes.

  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Dead cross was found 5 days back on short term averages

A Dead cross was found 2 days back on mid term averages

Support for tomorrow is 1.31 and resistance for tomorrow is 1.43
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.33, 1.29 resistance for tomorrow's hourly charts is 1.45, 1.53

10 Day SMA for Autolus Therapeutics (AUTL) is 1.49 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Autolus Therapeutics (AUTL) is 1.6 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Autolus Therapeutics (AUTL) is 1.52 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.52 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Autolus Therapeutics is 1.73 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Autolus Therapeutics is at 1.6 and 200 DMA is at 1.73, while 50 DMA and 100 DMA are at 1.52 and 1.52 respectively

Autolus Therapeutics (AUTL) moving average of 20 SMA is at 1.6 and 20 EMA is at 1.53

Autolus Therapeutics (AUTL) moving average of 50 SMA is at 1.52 and 50 EMA is at 1.55

Autolus Therapeutics (AUTL) moving average of 100 SMA is at 1.52 and 100 EMA is at 1.62

Autolus Therapeutics (AUTL) moving average of 200 SMA is at 1.73 and 200 EMA is at 1.86

Autolus Therapeutics has performed better than Qiagen N in short term. Holding Autolus Therapeutics could be a better choice for now!

Merck Company has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Merck Company, about 9.23% more returns!

Astrazeneca Plc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 5.76% more returns!

Xencor Inc has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Xencor Inc, about 19.09% more returns!

Autolus Therapeutics has performed better than Xeris Pharmaceuticals in short term. Holding Autolus Therapeutics could be a better choice for now!

Autolus Therapeutics has performed better than Siga Technologies in short term. Holding Autolus Therapeutics could be a better choice for now!

Oramed Pharmaceuticals has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 26.26% more returns!

Gilead Sciences has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 6.67% more returns!

Autolus Therapeutics has performed better than Guardant Health in short term. Holding Autolus Therapeutics could be a better choice for now!

Autolus Therapeutics has performed better than Geron Corporation in short term. Holding Autolus Therapeutics could be a better choice for now!

Denali Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Denali Therapeutics, about 15.6% more returns!

Autolus Therapeutics has performed better than Diamedica Therapeutics in short term. Holding Autolus Therapeutics could be a better choice for now!

Autolus Therapeutics has performed better than Dermira Inc in short term. Holding Autolus Therapeutics could be a better choice for now!

Dbv Technologies has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Dbv Technologies, about 6.03% more returns!

Allogene Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 13.5% more returns!

Aclaris Therapeutics has performed better than Autolus Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 30.09% more returns!

Autolus Therapeutics Technical analysis of indicators

Price action analysis of Autolus Therapeutics (AUTL) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Autolus Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Autolus Therapeutics in short term and the sell signal is strong.

Autolus Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Autolus Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Autolus Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.5 and Autolus Therapeutics AUTL stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Autolus Therapeutics AUTL stock. Volume based technical analysis of Autolus Therapeutics AUTL stock is negative.

Autolus Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock AUTL Autolus Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AUTL Experts View which covers a lot of information including buying and selling signals

AUTL future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Autolus Therapeutics or View Candle Stick Charts here

Chart Autolus Therapeutics (AUTL)  Technical (Analysis) Reports Autolus Therapeutics [

Videos related to: Autolus Therapeutics (AUTL) Technical (Analysis) Reports Autolus Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Autolus Therapeutics (AUTL)  Technical (Analysis) Reports Autolus Therapeutics [

 

Back to top